between primary infection and the development of AIDS Diana Finzi and Robert F. Siliciano Department of Medicine (Coombs et al., 1989; Ho et al., 1989; Piatak et al., 1993) . Primary HIV-1 infection is characterized by extremely The Johns Hopkins University School of Medicine Baltimore, Maryland 21205 high levels of plasma virus (Daar et al., 1991) . Values in excess of 10 6 copies of RNA/ml are commonly seen. As the immune response to HIV-1 develops, plasma virus levels fall to lower steady-state values that vary in differ-A great deal of progress has been made in understandent individuals and that are predictive of the rate of ing the molecular biology of HIV-1 replication (see redisease progression (Mellors et al., 1996) . In untreated views by Cullen [1998] , Chan and Kim [1998] , and Littasymptomatic patients, the plasma HIV-1 RNA levels man [1998] in this issue of Cell). Nevertheless, critical are typically in the range of 10 3 -10 6 copies/ml in blood. aspects of AIDS pathogenesis remain to be elucidated.
Titers of infectious virus are several orders of magnitude For example, it is still unclear how HIV-1 infection inlower, indicating that much of this plasma virus is defecduces CD4 ϩ T cell depletion, which is the central pathotive, decayed, or neutralized. physiologic feature of the disease. It is also uncertain During the asymptomatic phase of the infection, the how the virus persists in the presence of vigorous imlevel of plasma HIV-1 RNA is reasonably stable in a given mune responses. Recently, important insights into these individual in the short run (days to weeks). This reflects complex aspects of the host-pathogen interaction in a quasi-steady state in which virus production equals HIV-1 infection have come from a surprisingly simple virus clearance. The equilibrium has been formalized by approach, the direct measurement of circulating levels
Perelson and colleagues in the form of the equation P ϭ of free virus. The development of rapid, sensitive, and cV where P is the viral production rate, c is the viral accurate methods for quantitating virus particles in the clearance rate constant, and V is the number of plasma blood has greatly facilitated the study of AIDS pathogenvirions Perelson et al., 1996 Perelson et al., , 1997a . esis and the management of patients with HIV-1 infecAt a first approximation, the dynamics underlying this tion. Quantitative competitive RT-PCR is carried out on equilibrium between virus production and virus clearblood and other biological fluids to detect genomic viral ance can be represented as: RNA, which is present at two copies per virion (Piatak et al., 1993) . Because the rate of clearance of free virus dV/dt ϭ N␦T* Ϫ cV from the blood is largely independent of stage of disease and other factors, the level of viral RNA in the plasma in which N␦T * , the virus production term, is the product reflects the rate of virus production. Recent studies sugof the number of new virions produced per infected cell gest that the half-life of free virus particles is extremely (N), the rate of loss of productively infected cells (␦), and short, on the order of minutes to hours (Perelson et al., the number of productively infected cells (T   *   ) . At steady 1996). Thus, the steady-state level of viral RNA genomes state, dV/dt ϭ 0 and N␦T * ϭ cV. As is discussed below, in the blood reflects very recent virus production. As a perturbation of this equilibrium by treatment with antiretresult, physicians and investigators in this field have a roviral drugs has given important information about the tool that is available for few other infectious diseases, rates of virus production and the rates of clearance of a real-time measure of the rate of replication of the free virus particles (c) and of productively infected cells pathogen in the host. Analysis of dynamic changes in (␦). Perelson et al. have also constructed more elaborate the level of plasma virus at different stages of disease models that take into account virus production by differand in response to antiretroviral therapy has provided ent cell types with different rates of clearance. These some startling new insights into the mechanism of CD4 ϩ models have proven very useful in the analysis of viral T cell depletion, the reasons for drug failure, the nature reservoirs in infected individuals (Perelson et al., 1996 , of viral reservoirs, and the intriguing possibility that pro1997a). Before considering these models of viral dynamlonged therapy may lead to virus eradication. The meaics, it is worth reviewing in a qualitative sense where surement of viral dynamics in vivo is a new area of study, the plasma virus comes from and what happens to it. made possible by the availability of assays for free virus Current evidence favors the idea that most of the and of antiretroviral drugs that perturb the steady-state plasma virus comes from recently infected CD4 ϩ lymequilibrium between virus production and virus clearphoblasts in the peripheral lymphoid tissues. The infecance. It is likely that lessons learned will have broadtion of CD4 ϩ T cells by HIV-1 is best considered in the reaching influence on the study of other infectious discontext of the normal physiology of T cell activation eases. This review will discuss recent advances in the ( Figure 1 ). Uninfected CD4 ϩ T cells emerge from the study of viral dynamics, focusing on the possibility of thymus as naive cells and circulate until they encounter HIV-1 eradication with antiretroviral therapy.
antigen. They then undergo blast transformation and begin to proliferate. Some of the cells survive and return to a G 0 resting state in which they persist as memory The Steady State One important and incontrovertible principle to emerge cells able to respond again to subsequent encounters with the same antigen. Memory T cells are distinguishfrom measurements of plasma virus levels in HIV-1 infection is that viral replication continues throughout the able from naïve cells based on differential expression of adhesion molecules and altered triggering thresholds. disease, even during the prolonged asymptomatic phase ϩ T cells but may not the naïve and memory pools. In infected individuals, the proportion of activated cells increases. The fraction of infect resting cells readily because of the low expression of CCR5. In any event, the infection does not progress CD4 ϩ T cells that are infected has been controversial, but recent evidence suggests that for both resting and in resting cells due to a block prior to the stage of nuclear import of the preintegration complex containing activated CD4 ϩ T cells, the fraction of cells with stably integrated, replication-competent provirus is very small the reverse transcribed HIV-1 DNA. Resting cells with unintegrated HIV-1 DNA may represent a latent reservoir (Ͻ0.1%) (Chun et al., 1997a) . Among resting CD4 ϩ T cells, a higher fraction of cells (1%) may harbor unintefor the virus in the sense that if these cells are activated by antigen before the preintegration complex decays, grated HIV-1 DNA (Bukrinsky et al., 1991; Chun et al., 1997a) . then the subsequent steps of nuclear import, integration, virus gene expression and virus production occur
The dynamics of infection are somewhat different in the case of cells of the monocyte-macrophage lineage, (Zack et al., 1990; Bukrinsky et al., 1991 Bukrinsky et al., , 1992 Spina et al., 1995) . The major pathway to productive infection the other major cell lineage that is susceptible to infection in vivo (Ho et al., 1986; Gartner et al., 1986 ; Nicolson probably involves direct infection of activated CD4 ϩ T cells. These infected lymphoblasts are highly permissive et al., 1986) . Circulating monocytes, the precursors of tissue macrophages, do not show a significant level for viral replication and rapidly begin to produce virus. However, infected CD4 ϩ lymphoblasts die quickly (t1⁄ 2 ‫ف‬ of infection as assessed by DNA PCR, indicating that infection may occur after the monocytes have left the 1 day, see below) due to viral cytopathic effects and/or host cytolytic effector mechanisms. A small fraction of circulation and differentiated into macrophages (Schnittman et al., 1989) . In in vitro infections, macrophages do the productively infected cells may survive long enough to revert back to a resting memory state in much the not succumb to the cytopathic effects of HIV-1 infection. This observation has led to the suggestion that infected same way that noninfected CD4 ϩ lymphoblasts do. The resulting memory cells carry an integrated copy of the macrophages may represent a major reservoir for the virus in vivo. As is the case with CD4 ϩ T cells, only a HIV-1 genome. Because of the absence of activationdependent host transcription factors and insufficient minute fraction of the macrophage pool carry integrated provirus at any given time (Chun et al., 1997a) . Macrolevels of positive regulatory viral factors such as tat and rev, the integrated provirus in resting memory cells phages play an important role in the presentation of antigens to CD4 ϩ T cells, and it is possible that infected remains latent until the memory cell is reactivated by antigen (Folks et al., 1989; Pomerantz et al., 1990 Pomerantz et al., , 1992  macrophages may transmit the infection to CD4 ϩ T cells during antigen presentation. The same is true of bone Garcia-Blanco and Cullen, 1991; Seshamma et al., 1992) . These resting memory cells thus represent a second marrow-derived dendritic cells, which are highly specialized for antigen presentation (Cameron et al., 1992 ; type of latent reservoir for HIV-1, one with a great potential for stability resulting from the integrated nature of Pope et al., 1994) . The frequency and half-life of infected dendritic cells in vivo is unknown. the latent provirus and the long life span of the memory cells harboring the latent provirus.
The major site of virus replication appears to be in the peripheral lymphoid organs, such as the lymph It is also important to appreciate the pool sizes of the different cells represented in Figure 1 . In an uninfected nodes and the spleen, and in the mucosal lymphoid tissue (Pantaleo et al., 1991 (Pantaleo et al., , 1993 Embretson et al., 1993; Frankel et al., 1996; Veazey et al., 1998) . Pivotal early studies of lymph node biopsies from infected individuals demonstrated that the fraction of lymphoid cells that were infected with HIV-1 was higher in the lymph nodes than in the peripheral blood. This finding, together with the fact that the vast majority (98%) of lymphocytes are located in the peripheral lymphoid tissues, has given rise to the idea that these tissues are the major site of virus replication. Some of the virus produced within the lymph nodes is trapped on a specialized cell type known as a follicular dendritic cell (FDC), which is distinct from (Pantaleo et al., 1993) . FDCs are located in the germinal
The t 1⁄2 for the first phase of decay is based in the work of Shaw and centers of the secondary lymphoid organs where they
Ho and their colleagues (Wei et al., 1995; function to bind and present intact antigens to B lympho- al., 1996, 1997a) . The t1⁄ 2 of the second phase of decay is based on cytes. FDCs express Fc␥ and complement receptors the work of Perelson et al. (1997a) . The existence of a putative third that facilitate the trapping of immune complexes. In inphase of decay, reflecting the extremely slow turnover of a small number of latently infected resting CD4 ϩ T cells, is suggested.
fected individuals, virus particles that have reacted with anti-envelope antibodies may be trapped on FDCs creating a major potential reservoir. There is some evidence without preventing virus production by cells that have for retention of infectivity despite the coating of the already been infected. The rapid, exponential decline virion with antibody and complement that is necessary observed in treated patients was taken as evidence that for attachment to FDCs (Heath et al., 1995) . The FDC the drugs largely prevent any new infection of susceptinetwork is disrupted late in the course of disease at ble cells. In this situation, the observed decreases in a time when the concentration of plasma virus rises plasma virus levels reflect the intrinsic decay rates of (Pantaleo et al., 1993) . Increases in plasma virus may the various cellular and extracellular compartments that reflect the loss of the trapping function of FDC. Virions harbor virus. that are produced in the lymph nodes and fail to bind
In a subsequent study, Perelson and colleagues exto FDC can escape and enter the circulation.
amined plasma viral levels early after the initiation of To summarize, the prolonged asymptomatic phase of therapy in an effort to measure separately the two pro-HIV-1 infection is characterized by a steady state in cesses that contribute to the rapid initial decay of which continuous virus production is balanced by virus plasma virus: the clearance of free virions and the loss clearance. Most of the plasma virus is produced by of the infected cells that produce most of the plasma infected CD4 ϩ lymphoblasts in the peripheral lymphoid virus (Perelson et al., 1996) . This was done by solving tissues. Mechanisms of virus clearance remain unclear. a set of differential equations describing the dynamics A much better understanding of the dynamics of HIV-1 of cell infection and virion production and by fitting the infection was achieved when antiretroviral drugs were decay data to the derived model. In this way, the decay used to perturb this steady state. rate constants for free virus (c) and for the cells that produce most of the plasma virus (␦) were calculated.
The resulting values for c were strikingly similar in differThe First Phase of Decay ent patients, consistent with the idea that c is an intrinsic In 1995 the laboratories of George Shaw at the University decay rate of a particular compartment. The same was of Alabama and David Ho at the Aaron Diamond AIDS true for ␦. Mean values for c and ␦ were 3 and 0.5 Research Center published profoundly influential paday
Ϫ1
, respectively. These rate constants are most easily pers describing the effects of potent new inhibitors of evaluated in the form of half-lives (t1⁄ 2 ϭ ln2/c, ln2/␦). For HIV-1 reverse transcriptase and protease on plasma vifree virus, t 1⁄2 was Ͻ6 hr. For productively infected cells, remia in HIV-1-infected patients (Wei et al., 1995; t 1⁄2 was ‫2-1ف‬ days. Direct confirmation of the rapid turnal., 1995). These papers not only changed the course over of productively infected cells has been provided of AIDS therapy but also provided critical insights into by Haase and colleagues using in situ hybridization analthe pathogenesis of the disease. The critical finding was ysis of tonsillar biopsies from patients starting antiretthat potent antiretroviral drugs produced a very rapid roviral therapy (Cavert et al., 1997) . The lability of both exponential drop in the level of plasma virus. Typically, the plasma virus and the cells that produce most of the plasma virus levels decreased 100-fold in two weeks plasma virus underscores the fact that virus replication (Figure 2) . Analysis of this rapid decline led to the concluis active and ongoing throughout the course of the dission that HIV-1 infection is a dynamic process characterease. HIV-1 is cytopathic for CD4 ϩ T cells, and it is ized by continual new rounds of viral infection of and likely that the short-lived cells that produce most of the replication in susceptible cells. Most of the plasma virus plasma virus are CD4 ϩ T lymphoblasts. A corollary is is produced by recently infected cells. Neither the free that long-lived infected cells such as macrophages and virus nor the cells that produce most of the plasma virus latently infected T cells must make only a minor contrisurvive very long. It is important to recall that both the bution to plasma viremia in untreated patients. reverse transcriptase inhibitors and the protease inhibiMeasurement of the viral clearance rate c allows calculation of P, the rate of virus production, using the tors act to prevent new infection of susceptible cells equation P ϭ cV. Figures in excess of 10 10 virions per studies showed that combinations of antiretroviral agents could produce a decline in plasma virus to undetectable day have been reported (Perelson et al., 1996) Coffin, 1995) . The high rate of virus producthat, after the rapid initial decay during the first 1-2 tion, when considered in the context of the short halfweeks of treatment, plasma virus declined at a slower life of cells that produce most of the plasma virus, sugrate, reflecting the turnover of a longer-lived viral resergests that the rate of new infection of CD4 ϩ T cells voir or infected cell population (Figure 2 ). This reservoir is substantial. Uncertainty over the number of virions accounts for only a small portion of the total virus proproduced per infected cell (the burst size, N) makes it duction in an untreated individual and becomes evident difficult to calculate precisely the number of produconly when the cells that produce most of the plasma tively infected cells (T*) from the steady-state relationvirus have largely decayed. The half-life of the compartship N␦T* ϭ cV. However, Haase and colleagues have ment responsible for this second phase of decay was estimated T* by using in situ hybridization to detect cells estimated to be 1-4 weeks (Perelson et al., 1997a) . A expressing HIV-RNA in the lymphoid tissue (Haase et biphasic decay process was also observed directly in al., 1996). The total body value obtained, 4 ϫ 10 7 cells, in situ hybridization studies of productively infected mowas in good agreement with estimates based on quantinonuclear cells in the lymphoid tissues (Cavert et al., tation of integrated HIV-1 DNA in activated CD4 ϩ T cells 1997). in the lymph nodes (Chun et al., 1997a) . Because of the In many patients on highly active antiretroviral therapy technical difficulties involved, these approaches may (HAART), the second phase of decay brings levels of underestimate the number of productively infected CD4 ϩ plasma virus down to below the limit of detection of T cells. Nevertheless, it is clear that in an untreated current assays (20-500 copies/ml). Perelson et al. have patient, large numbers of CD4 ϩ T cells become infected used the careful analysis of second phase decay rates daily. The reverse transcription process that occurs in to make the first rational predictions of treatment times each of those newly infected cells has a sufficiently high required for virus eradication, with the caveat that there error rate that viral genomes with every possible single may be undetected compartments or viral reservoirs point mutation arise daily (Coffin, 1995 , 1997a) . If it is assumed that there are no fected per day, then not only are all possible single point additional reservoirs, the second phase of decay extrapmutations generated daily, but almost 1% of all possible olates to zero residual infected cells in 2-3 years of double mutations are generated each day (Perelson et completely suppressive antiretroviral therapy. al., 1997b) . This finding has enormous implications for
The nature of the viral reservoir that is responsible for understanding the evolution of drug resistance mutaproducing most of the plasma virus during this second tions and viral escape from immune effector mechaphase is unclear. One idea is that this virus is derived nisms.
from infected macrophages that turn over much more The high rate of virus production also has implications slowly than infected CD4 ϩ lymphoblasts (Perelson et for the debate over mechanisms of CD4 ϩ T cell depleal., 1997a). The observed decay rate is compatible with tion. Whether the direct killing of HIV-1-infected CD4 ϩ measured rates for the turnover of macrophages in unin-T cells is the cause of CD4 ϩ T cell depletion has been fected individuals. It remains unclear whether the numa central issue in AIDS research. The characteristics ber of macrophages infected in vivo is sufficient to acof the first phase of decay suggest that productively count for the requisite level of virus production during infected cells die quickly, but it has been unclear the second phase. Virions trapped on FDC also decline whether this effect alone is sufficient to account for in this time scale in individuals treated with HAART (Ca-CD4 ϩ T cell depletion. A major problem is the absolute vert et al., 1997). number of CD4 ϩ T cells that die per day from infection is still unknown. The increase in CD4 ϩ T cell counts
The Third Phase of Decay following initiation of HAART therapy is undoubtedly due Despite the dramatic success of HAART in reducing in part to a decrease in virus-induced cell killing, but plasma viremia to undetectable levels in some patients, quantitative analysis of CD4 ϩ T cell reconstitution is there has been the concern that the infection will be complicated by the fact that early increases in CD4
"rekindled" if therapy is withdrawn. In patients who excounts may reflect a redistribution of CD4 ϩ T cells from perience complete suppression of new cycles of replicathe secondary lymphoid organs with a late component tion for the estimated 2-3 years required for the second of increased production of naïve cells (Autran et al., phase of decay to be complete, the residual virus that 1997). Additional factors to be considered include the would rekindle the infection could only come from a possibility that CD4 depletion is due to effects on thycompartment with the following two characteristics. mopoeisis Su et al., 1995) or to indiFirst, this compartment would have to be extremely starect effects on uninfected CD4 ϩ T cells (Banda et al., ble. Second, it would have to be responsible for produc-1992; Finkel et al., 1995) . An excellent review of these ing only a minute fraction of the plasma virus in untreated complex issues has recently been published (Hellerstein individuals since the cells that produce most of the and McCune, 1997) . plasma virus decay quickly. As shown in Figure 2 , the existence of such a compartment cannot be ascertained The Second Phase of Decay from the measurement of plasma HIV-1 RNA levels beAlthough drug resistance developed rapidly in patients cause of the difficulties involved in quantitating extremely low levels of plasma virus. Therefore alternative treated with protease inhibitors as monotherapy, further approaches are needed to demonstrate the existence of compartments responsible for a putative third phase of decay.
Several recent studies suggest that latently infected resting memory CD4 ϩ T cells with integrated provirus represent an extremely stable reservoir for HIV-1 that may be responsible for the third phase of decay in patients on HAART (Chun et al., 1995 (Chun et al., , 1997a (Chun et al., , 1997b Finzi et al., 1997; Wong et al., 1997b) . The importance of this reservoir derives from a fundamental aspect of the biology of memory cells; these cells must survive for long periods of time in order to provide protection against previously encountered pathogens. Although it has been presumed that the integration of HIV-1 DNA into the genomes of infected CD4 ϩ T lymphocytes allows viral persistence, there has been until recently little direct evidence that resting memory CD4 ϩ T cells with (1996) . The half-life of the cells that produce most of the plasma latent infection (Folks et al., 1989; Pomerantz et al., 1990) virus was measured by Wei et al. (1995) and by Ho and colleagues and have provided a great deal of information about Perelson et al., 1996 Perelson et al., , 1997a . The most recent estimates suggest a half-life of 1 day. The stability of the unintethe molecular mechanisms involved in the regulation tic of memory cells (Chun et al., 1997a) . (Perelson et al., 1997a; Cavert et al., 1997; Michie, 1995). et al., 1997a) , it has often been presumed that the proviral DNA burden in T cells represents mainly defective archival sequences. In fact, it is often difficult to isolate in a latent form in resting CD4 ϩ T cells raises the possibil-HIV-1 from T cells of patients on long-term HAART using ity that this reservoir might represent a major barrier to conventional virus culture methods. However, with envirus eradication in patients on HAART. hanced virus culture conditions designed to induce uniThree recent studies examined whether replicationform activation of resting CD4 ϩ T cells, replication-comcompetent virus could persist in the resting CD4 ϩ T cells petent virus can be recovered from highly purified of patients on HAART (Finzi et al., 1997; Wong et al., resting CD4 ϩ T cells (Chun et al., 1997a) . The frequencies 1997b; Chun et al., 1997b) . These studies focused on a of resting CD4 ϩ T cells with replication-competent provisubset of patients who responded extremely well to rus are lower than the frequencies of resting CD4 ϩ T therapy and who had been aviremic for as long as 2.5 cells with integrated HIV-1 DNA (as detected by inverse years. Although it is generally very difficult to isolate PCR). This suggests that some of the integrated HIV-1 virus from patients on long term HAART by conventional DNA in resting CD4 sponses, could eventually allow immunologic control of Folks, T.M., Clouse, K.A., Justement, J., Rabson, A., Duh, E., Kehrl, viruses originating from this reservoir (Rosenberg et al., J.H., and Fauci, A.S. (1989) . Tumor necrosis factor alpha induces 1997).
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